Eleanor Namusoke Magongo is a Paediatrician & Child Health Specialist with 15 years’ experience leading teams to design, implement, monitor and scale up pediatrics and adolescent HIV programs in Uganda. She has worked at the Ministry of Health, AIDS Control Program for ten years now, and she leads the national program for children and adolescents living with HIV. She successfully led the development of a decentralized HIV Drug Resistance (HIVDR) and third-line ART program in Uganda, a model program on the African continent. She is a member of the WHO Adolescent HIV Service Delivery Technical Working Group (ASWG), Child Survival Working Group (CSWG) and WHO HIV Drug Resistance Steering Group. She is also the Co-Chair of the WHO HIV Drug Resistance Governance and Enabling Mechanism Working Group. Dr. Magongo has participated in development of WHO-lead technical briefs for children and adolescents living with HIV. She is a member of the NIH-Fogarty funded Adolescent HIV Prevention and Treatment Implementation Science Alliance (AHISA) and is a fellow at the HIV, Infectious Disease and Global Health Implementation Science Research (HIGH-IRI) Institute at the Washington University in St Louis Missouri USA. She is the founder of the Paediatrics and Adolescent HIV Learning Collaborative for Africa (PAHLCA), a meeting that brings together Ministry of Health Paediatrics and Adolescent HIV programme managers and their respective country stakeholders from over 30 African countries to promote peer-to-peer learning. Dr. Magongo is also the founder of the International Paediatrics HIV/AIDS Symposium for Africa (IPHASA, WWW.IPHASA.ORG), an abstract-driven meeting, that provides a platform for young African researchers and different stakeholders, to share research findings on children and adolescents living with HIV. She has integrated Implementation Science Research capacity building sessions into the PAHLCA and IPHASA meetings. Dr. Magongo’s research interest is in HIV viral load suppression and HIV drug resistance. She has committed her efforts to design strategies to improve viral load suppression, and to prevent development of HIV drug resistance among children and adolescents living with HIV. She has established the Uganda Pediatrics ART (UP-ART) cohort in Uganda that utilizes real-world Electronic Medical Records (EMR) data to guide evidence-based implementation. The cohort has a nested HIVDR sub-study and has enrolled over 1500 children and adolescents at three health facilities and will be expanding to 4 additional health facilities. She is also a member of the Scientific Advisory Committee for the East African Point of Care (EAPOC) Viral load multinational study and a member of the PENTA ID Network, a global paediatric research network.
